Amer Jamalpoor

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Induced Apoptosis

Chronic Lymphocytic Leukemia

Combination Therapy

Top Venues

Birth defects research

EMBO molecular medicine

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Amer Jamalpoor, Sabine Hartvelt, Myrto Dimopoulou, Tom Zwetsloot, Inger Brandsma, Peter I Racz, Torben Osterlund, Giel Hendriks
A novel human stem cell-based biomarker assay for in vitro assessment of developmental toxicity. Birth defects research 114 (19) (2022)
Amer Jamalpoor, Charlotte Agh van Gelder, Fjodor A Yousef Yengej, Esther A Zaal, Sante P Berlingerio, Koenraad R Veys, Carla Pou Casellas, Koen Voskuil, Khaled Essa, Carola Me Ammerlaan, Laura Rita Rega, Reini E N van der Welle, Marc R Lilien, Maarten B Rookmaaker, Hans Clevers, Judith Klumperman, Elena Levtchenko, Celia R Berkers, Marianne C Verhaar, A F Maarten Altelaar, Rosalinde Masereeuw, Manoe J Janssen
Cysteamine-bicalutamide combination therapy corrects proximal tubule phenotype in cystinosis. EMBO molecular medicine 13 (7) (2021)
Johannes J M Rood, Amer Jamalpoor, Stéphanie van Hoppe, Matthijs J van Haren, Roeland E Wasmann, Manoe J Janssen, Alfred H Schinkel, Rosalinde Masereeuw, Jos H Beijnen, Rolf W Sparidans
Extrahepatic metabolism of ibrutinib. Investigational new drugs 39 (1) (2020)